>

ISHARES Fundamentals

FXC
ISHARES CHINA fundamental analysis lookup allows you to check this and other indicators for ISHARES CHINA LARGE CAP UCITS E or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools
View Fundamentals For
Refresh

ISHARES Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
P/S 
 = 
MV Per Share 
Revenue Per Share 
More About Price to Sales | All Equity Analysis

Current ISHARES CHINA LARGE CAP UCITS E Price to Sales

1.14 
ValuationFinancialsBuy or Sell

About Price to Sales

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.Compare to competition
Based on latest financial disclosure the price to sales indicator of ISHARES CHINA LARGE CAP UCITS E is roughly 1.14 times. This is 40.74% higher than that of the BlackRock Asset Management Ireland - ETF sector, and 40.74% higher than that of Price to Sales industry, The Price to Sales for all etfs is 245.45% lower than the firm.

ISHARES CHINA LARGE Fundamental Drivers Relationships

ISHARES CHINA LARGE CAP UCITS E cannot be rated in Price to Sales category at this point. It cannot be rated in Price to Earning category at this point. reporting about  8.63  of Price to Earning per Price to Sales.

Did you try this?

Run CEO Directory Now

   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Fund Asset Allocation for ISHARES CHINA

The fund consists of 98.26% investments in stocks, with the rest of investments allocated between various types of exotic instruments.
 Value 
    
  Instrument Type 

ISHARES Fundamentals

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Investing Opportunities. Please also try CEO Directory module to screen ceos from public companies around the world.


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page